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Background: Sepsis is a serious and potentially life-threatening condition and early diagnosis and appropriate treatment
is crucial for survival. Pyometra is one of the most common diseases in intact female dogs. The disease often leads to
sepsis (systemic inflammatory response syndrome, SIRS, caused by infection). Diagnostic markers for detecting sepsis are
gaining increasing interest in veterinary medicine. Acute phase proteins (APPs) such as C-reactive protein (CRP) are useful
for detecting systemic inflammation in dogs. Serum amyloid A (SAA) is another major APP in dogs that is not yet as
widely used. Albumin is regarded as a negative APP and has earlier been evaluated for prediction of prognosis in septic
dogs. The aim of the present study was to determine SAA, CRP and albumin concentrations in dogs with sepsis
and pyometra and to evaluate whether these inflammatory markers are associated with length of postoperative
hospitalization.
Results: Thirty-one surgically treated bitches with pyometra were included, whereof 23 septic (SIRS-positive) and eight
non-septic (SIRS-negative). Albumin concentrations were analyzed by routine automated methods. SAA and CRP
analyses were performed with previously validated commercially available assays (ELISA and immunoturbidimetric).
Mean (±SE) serum concentrations of SAA were significantly higher in septic (130.8 ± 8.0 mg/L) compared to non-septic
bitches (88.5 ± 12.5 mg/L). Using a cut-off value for SAA of 109.07 mg/L (n = 31 bitches), the sensitivity and specificity
for detecting sepsis was 74% and 50%, respectively. Serum albumin concentrations were not significantly different in
septic compared to non-septic bitches (mean ± SE, 25 ± 1 g/L and 26 ± 1 g/L, respectively). CRP concentrations were
also not significantly different in septic (mean ± SE 225.6 ± 16.0 mg/L) compared to non-septic bitches (mean ± SE,
176.0 ± 27.1 mg/L). None of these inflammatory markers were associated with the outcome as measured by length of
hospitalization.
Conclusions: SAA concentrations were increased in dogs with sepsis induced by pyometra and may be useful as an
adjunctive diagnostic marker for sepsis. To evaluate the full potential of SAA as a marker for sepsis also in other
diseases, further studies are warranted.
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Pyometra, purulent bacterial infection of the uterus, is a
common diagnosis in intact female dogs. Differences in
incidence rates between breeds are reported [1,2]. Ovar-
iohysterectomy (OHE) is the treatment of choice, but is
not always life-saving. The mortality ranges between 3-
10% [2,3]. Gram-negative bacteria, mainly Escherichia* Correspondence: Supranee.Jitpean@slu.se
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unless otherwise stated.coli (E. coli), are most often isolated from the uterus
[4,5]. Gram-negative bacteria contain endotoxin which is
released during bacterial growth or death, and endotoxin
present in the bloodstream is a potent inducer of sys-
temic inflammation [6]. Several studies have reported
that the majority of dogs with pyometra also suffer from
sepsis (i.e. sepsis defined as systemic inflammatory syn-
drome, SIRS, caused by infection) [7,8]. Sepsis is a ser-
ious condition frequently leading to organ dysfunctions
in animals and humans. Despite modern treatments,
sepsis associated with organ dysfunctions is a main cause
of death (more than 40%) in human intensive care units
[9]. Early diagnosis and appropriate treatment of sepsisLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Case history and physical examination findings in
31 bitches with pyometra
Variable Number of bitches with abnormality
of variable/number of bitches



















Abdominal pain on palpation 3 (7%)
CRT = Capillary refill time.
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challenging because clinical signs and results of labora-
tory variable analyses are not unique for septic patients
and there is no reliable diagnostic marker. In pyometra,
certain clinical and laboratory analysis results can be
valuable in the prediction of outcome as measured by
prolonged postoperative hospitalization and presence of
peritonitis [3]. The bacterial infection of the uterus stim-
ulates the release of cytokines, lymphokines and other
chemical mediators, which in turn trigger hepatic produc-
tion of acute phase proteins [7,11,12]. Successful surgical
treatment of the disease leads to rapid improvement of
abnormalities in hematological, biochemical and in-
flammatory variables [3,13]. In human medicine, ana-
lysis of C-reactive protein (CRP) and procalcitonin are
widely used for diagnosing inflammatory diseases and
to predict outcome and increased concentrations are
observed in septic patients [14-23]. In veterinary medi-
cine, CRP and SAA have been investigated for diagnos-
tic and prognostic purposes in several diseases
[7,24-28]. Moreover, it has been reported that SAA ana-
lysis was valuable for identifying malignancy associated
with inflammation in humans [29-32]. In dogs, it has
been reported that SAA concentrations are less fre-
quently increased in healthy dogs compared to CRP
which indicates that SAA may be a more specific
marker for systemic inflammation [33,34]. Albumin is
considered to be a negative acute phase protein because
serum concentrations decrease in inflammation and/or
infection. Hypoalbuminemia in response to infection or
inflammation is likely due to decreased production by
the liver and/or increased vascular permeability that
may lead to extravasal accumulation of albumin [35].
Albumin concentrations decrease in sepsis and may be
valuable as a negative prognostic biomarker for survival
[36-38]. Although controversial, albumin has been used
as adjunctive treatment in septic animals [39,40].
Serum albumin is routinely analyzed in clinical labora-
tories and therefore accessible in most veterinary
clinics. SAA has so far not been investigated in sepsis
and associations between SAA, CRP and albumin have
not been assessed in canine pyometra. The aim of the
present study was to determine SAA, CRP and albumin
concentrations in dogs with sepsis and pyometra and to
evaluate whether these inflammatory markers are asso-
ciated with length of postoperative hospitalization.Results
Animals-general data
Physical examination findings
In this study, common clinical signs of pyometra in-
cluded depression, anorexia, vaginal discharge, polydip-
sia, and polyuria (Table 1).Bacteriological findings
Escherichia coli (E. coli) was isolated from the uterine
content in 25/31 bitches (81%). Other bacterial species
isolated were β-hemolytic streptococci in 7/31 bitches
(23%) and Proteus spp in 1/31 bitch (3%). Of these,
two bitches had growth of two bacterial species, one
bitch with E. coli and β-hemolytic streptococci, one
bitch with Proteus spp and β-hemolytic streptococci.
Bacterial blood cultures were positive in three of 27
sampled bitches (11%) and E. coli was demonstrated in
two bitches and β-hemolytic streptococci in one bitch
(the same pathogens were also demonstrated in the
uterine cultures from each of these bitches).Sepsis
In all bitches with pyometra, the mean age and weight
was 7.7 ± 2.4 years and 27.1 ± 11.7 kg. The mean age
and weight in the septic group was 8.1 ± 2.3 years and
28.9 ± 12.5 kg. In the non-septic group the mean age
and weight was 6.6 ± 2.6 years and 21.9 ± 7.5 kg. The
weight and age did not differ between the septic and
non-septic bitches.
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The number of band neutrophils, monocytes and baso-
phils were significantly higher in septic bitches com-
pared to the non-septic group (p <0.05) (Table 2).
Inflammatory markers
The mean SAA concentration were significantly higher
in septic compared to non-septic bitches (p = 0.006)
(Table 3 and Figure 1). If a cut-off value of SAA of
109.07 mg/L was selected (n = 31 bitches), the sensitiv-
ity and specificity for detecting sepsis was 74% and
50%, respectively. The Receiver operating characteristic
curve (ROC) analysis displayed an area under the curve
(AUC) of 0.74 for SAA in the dogs with sepsis (p = 0.04)
(Figure 2). In four bitches with sepsis and one non-septic
bitch, the SAA concentration exceeded 180 mg/L (sample
dilution up to 1/8 000). The mean concentrations of
CRP and serum albumin were not significantly higher
in septic compared to non-septic bitches (p = 0.1 and
p = 0.7, respectively) (Table 3). In the three bitches with
positive blood cultures (bacteremia), the concentrations
of CRP were 97, 272 and 298 mg/L, concentrations of
SAA were 56.6, 114.7 and 117.9 mg/L and concentra-
tions of albumin 21, 26 and 20 g/L. Four out of 23
bitches in septic group required prolonged hospitalization.
In the non-septic group, none of the bitches stayed
longer in the hospital than two days after surgery. NoneTable 2 Clinical and laboratory findings in the 23 septic and
Pyometra
Variable Septic mean ± SE (n) (range) Non-sept
BT (°C) 39.2 ± 0.1 (23) (38.3-40.5) 38.6 ± 0.2
RR (breaths per minute) 69 ± 14 (17) (15-260) 19 ± 22 (7
HR (beats per minute) 106 ± 4 (20) (72-150) 94 ± 9 (8)
Hemoglobin (g/L) 132 ± 4 (23) (93-173) 116 ± 7 (8
Hematocrit (%) 37 ± 1 (28-40) 34 ± 2 (25
WBC (×109/L) 24.2 ± 3.0 (23) (2.8-106.4) 16.7 ± 5.0
Neutrophils (×109/L) 13.9 ± 2.6 (23) (1.4-85.1) 11.8 ± 4.4
Band neutrophils (×109/L) 5.5 ± 0.7 (23) (0.6-4.4) 2.1 ± 1.3 (
Lymphocytes (×109/L) 1.9 ± 0.2 (23) (0-4.9) 1.2 ± 0.4 (
Monocyte (×109/L) 2.6 ± 0.3 (23) (0.2-6.4) 1.4 ± 0.4 (
Eosinophils (×109/L) 0.3 ± 0.1 (23) (0-1.9) 0.2 ± 0.2 (
Basophils (×109/L) 0 ± 0 (23) (0-0) 0.08 ± 0.0
Bile acids (μmol/L) 4.5 ± 1.4 (23) (0.3-20.4) 4.9 ± 2.4 (
ALT (μkat/L) 0.4 ± 0.1 (22) (0.05-1.3) 0.4 ± 0.1 (
Glucose (mmol/L) 4.9 ± 0.2 (20) (2.9-6.8) 5.4 ± 0.4 (
BUN (mmol/L) 3.6 ± 0.3 (23) (1.5-7.4) 2.8 ± 0.5 (
Serum creatinine (μmol/L) 66 ± 3 (22) (48-100) 61 ± 5 (8)
BT = Body temperature, RR = Respiratory rate, HR = Heart rate, WBC = Total white b
†Reference range (at the Clinical Pathology Laboratory, University Animal Hospital, S
¶Reference range by Ettinger and Feldman, Textbook of Veterinary Internal Medicinof the inflammatory markers investigated (SAA, CRP,
albumin) were associated with prolonged postoperative
hospitalization.
Discussion
Concentrations of SAA were higher in bitches with sep-
sis compared to those without sepsis. This is the first
time that a possible clinical value of SAA analysis for
identification of sepsis in dogs is reported. However, the
cut-off value for SAA of 109.07 mg/L used, yielded a
sensitivity of 74% for detecting bitches with sepsis which
is lower than the 97% sensitivity reported previously
when using the clinical criteria HR, RR, WBC/percent-
age band neutrophils and rectal temperature for deter-
mination of SIRS [42]. Using criteria for sepsis that have
high sensitivity is more important than a high specificity
because including non-septic bitches in the septic group
would not endanger their condition. But to include truly
septic bitches in the non-septic group with less optimal
treatment could have serious consequences for the indi-
vidual bitch. A specificity of 50% means that SAA can-
not be used as a single variable for diagnosing sepsis
because 50% truly septic bitches would be classified as
non-septic. The low specificity was not surprising be-
cause SAA is regarded as an unspecific variable because
concentrations increase in all diseases with systemic in-
flammation. However, SAA could be a potential adjunctive8 non-septic bitches with pyometra
ic mean ± SE (n) (range) p value (ANOVA) Reference range†
(8) (37.8-39.4) 0.005 38-39¶
) (16-32) 0.08 20-40¶
(80-110) 0.15 80-120¶
) (89-134) 0.06 132-199†
-36) 0.2 38-57†
(8) (11.3-31.2) 0.2 5.8-16.0†
(8) (7.1-22.5) 0.7 3.0-11.5†
8) (0.6-18.1) 0.02 0.0-0.3†
8) (0.2-2.4) 0.17 1.4-4.8†
8) (0.2-4.4) 0.03 0.2-1.4†
8) (0-0.6) 0.7 0.1-1.2†
3 (8) (0-0.6) 0.03 0.0-0.1†
8) (0.3-12.3) 0.9 0.0-12†
8) (0.2-0.7) 0.9 0.0-1.3†
7) (2.9-7.3) 0.3 4.5-5.8†
8) (1.6-3.6) 0.3 2.5-8.8†
(41-81) 0.4 40-130†
lood cell count, ALT = Alanine aminotransferase, BUN = Blood urea nitrogen.
wedish University for Agricultural Sciences, Uppsala).
e, 2010 [41].
Table 3 Mean ± SE serum concentrations of Serum amyloid A (SAA), C-reactive protein (CRP) and albumin in septic and
non-septic bitches with pyometra
Pyometra (n = 31)
Variable Septic mean ± SE (n = 23) (range) Non-septic mean ± SE (n = 8) (range) p value (ANOVA)
SAA (mg/L) 130.8 ± 8.0 (52.3-180.0) 88.5 ± 12.5 (5.0-180.0) 0.006
CRP (mg/L) 225.6 ± 16.0 (49.0-362.0) 176.0 ± 27.1 (2.5-316.0) 0.1
Serum albumin (g/L) 25 ± 1 (16-32) 26 ± 1 (21-33) 0.7
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clinical SIRS criteria or other markers that increase the
sensitivity and specificity for sepsis diagnosis. SAA con-
centrations were significantly increased in septic dogs
which points to a possible higher clinical value for SAA in
the detection of sepsis compared with CRP, and this po-
tential deserves to be further investigated. A larger study
is necessary to investigate if a clinically useful cut-off value
for SAA in sepsis (with higher sensitivity and specificity)
can be established.
In this study, the finding of a clinical value of SAA is
in line with other studies in which SAA has shown
more promise as a diagnostic marker than CRP for gastro-
intestinal disorders linked with inflammation [33,34]. In
human medicine, SAA has also been shown to be a better
prognostic marker for severity of cancer associated with
inflammation [29,30,32,43]. Though not caused by infec-
tion, this points to a diverse capacity of CRP and SAA and
that there are conditions or diseases for which SAA could
have a clinically higher diagnostic or prognostic value thanFigure 1 Boxplot graph illustrating Serum amyloid A concentrations in
with pyometra including in this study.the more frequently used CRP. That CRP and SAA levels
have different diagnostic abilities in spite of both being
major acute phase proteins in dogs is in agreement with
the findings of one study in which CRP concentrations
were only moderately positively correlated with SAA con-
centrations [44].
Concentrations of albumin were not significantly dif-
ferent in bitches with or without sepsis. This finding was
unforeseen since lower albumin concentrations have
been reported in sepsis and decrease in experimentally
induced endotoxemia in dogs, cats and rats [35,45,46].
However, the clinical situation is different from experi-
mental studies in that the studied dogs were admitted at
various stages of disease progression and the effect of
endotoxemia may therefore be less prominent. Albumin
might have a diagnostic value in dogs with pyometra
and more severe disease (septic peritonitis or septic
shock), but this needs to be further studied. Hypoalbu-
minemia was earlier detected in 81% (25 out of 31, data
not shown) of these bitches with pyometra which is inbitches with pyometra. Eight non-septic bitches and 23 septic dogs
Figure 2 Receiver operating curve (ROC) illustrating the diagnostic power of Serum amyloid A (SAA). There were investigated in 31 bitches
with pyometra.
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could be interesting to study as a possible sepsis marker
[35,45,46]. Gram-negative bacteria, foremost E. coli, were
isolated from the uterine content which is similar to most
other studies of the disease [4,5,47]. That pyometra in-
duces hypoalbuminemia is not surprising because hy-
poalbuminemia has been reported as an effect of
Gram-negative infection and bacteremia [45]. To date,
no study has specifically investigated albumin as a marker
for sepsis in dogs. The results presented here suggest that
albumin could be clinically useful as an adjunctive marker
for diagnosis of pyometra, but albumin does not seem to
be as valuable as SAA in the detection of sepsis.
Increased concentrations of CRP have previously been
shown to be associated with presence of SIRS and pro-
longed hospitalization in bitches with pyometra, support-
ing the usefulness of CRP analysis in clinical practice [7].
Moreover, increased CRP concentrations have been associ-
ated with increased mortality in dogs with SIRS and sepsis
[26]. In the present study, higher CRP concentrations were
not associated with sepsis which is in contrast to a previous
report [7]. This report was larger, including 30 septic and23 non-septic bitches, which could somewhat explain the
difference in results, since otherwise the sampling methods
and patient inclusion criteria were similar. Pyometra often
induces sepsis, as demonstrated in the present study where
74% of the bitches were SIRS-positive. This proportion is
of the same magnitude (57-69%) as has been reported pre-
viously in the disease [7,47]. However, by using the selected
SIRS-criteria with a specificity of 64%, 36% non-septic
bitches will be included in the septic group [42]. There are
several criteria are available to define SIRS in dogs, based
on the different cut-off values with different specificity and
sensitivity [42,48,49]. Using SIRS-criteria with the highest
sensitivity (97%) available is advisable since it is important
to not clinically misdiagnose a truly septic dog as non-
septic which could lead to less optimal monitoring and
treatment resulting in a poor outcome. However, the lack
of more specific clinical criteria available for sepsis is a
limitation of the study. Another limitation is that the sam-
ples were freeze-stored up to 8 months before analysis.
However, CRP and SAA have been shown to be very
stable at room temperature and storage [50-53]. Depres-
sion, anorexia, polydipsia/polyuria and vaginal discharge
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phasizing the systemic effects of the illness in the studied
bitches [3,25,47]. Of all hematology and biochemistry vari-
ables analyzed, band neutrophils, basophils and mono-
cytes were increased in septic bitches. These results were
in line of other studies in response to infection and
chronic disease [54,55]. Because band neutrophils and
WBC are included in the criteria used to define sepsis,
these and other variables linked with WBC can there-
fore not be considered as independent. For prediction
outcome, as measured by length of hospitalization, none
of the markers analyzed in the present study were use-
ful, but a larger study material would be beneficial for
further evaluation.
Conclusion
SAA concentrations were increased in dogs with sepsis
induced by pyometra whereas concentrations of CRP
and albumin did not differ between septic and non-septic
bitches. This indicates that SAA may have a potential clin-
ical value for the detection of sepsis. The selected cut-off
value to investigate the ability of SAA as marker for sepsis
resulted in relatively low sensitivity and specificity suggest-
ing that SAA cannot be used as a single marker for this
purpose. Further studies of larger patient groups should
be performed to evaluate the potential value of SAA in the
detection of sepsis in dogs.
Methods
Study design and ethical approval
The study was designed as a prospective clinical study
and was approved by the Uppsala Local Ethical Board
(permission number C413/12). A signed informed con-
sent was obtained from the dog-owner before participa-
tion of their dog in the study.
Animals
Thirty-one client-owned bitches of 18 different breeds,
Airedale Terrier ( n = 1), Beagle (n = 1), Bernese Mountain
Dog (n = 2), Cane corso (n = 1), Cavalier King Charles
Spaniel (n = 2), Chow-Chow (n = 1), Collie (n = 2), Drever
(Swedish hound) (n = 1), English Springer Spaniel (n = 1),
German Shepherd Dog (n = 3), Giant Schnauzer (n = 2),
Golden Retriever (n = 3), Labrador Retriever (n = 1),
Mixed-Breed Dog (n = 3), Münsterländer (n = 1), New-
foundland (n = 1), Staffordshire Bull Terrier (n = 4) and
Standard Poodle (n = 1) were included in the study per-
formed as part of a project concerning inflammation
[44]. Complete physical examination was performed by
the veterinarian in charge, and the results filled in a spe-
cial form. Preliminary diagnosis of pyometra was based
on case history data, finding on physical examination
and diagnostic imaging by either abdominal ultrasonog-
raphy or radiology or both. All bitches were treated byOHE at the University Animal Hospital (UDS), Swedish
University of Agricultural Sciences (SLU), Uppsala, during
2011. The bitches were selected based on owner agree-
ment, daytime admission (Clinical Pathology Laboratory
access) and that at least one of the authors was on clinical
rotation. The diagnosis was confirmed by postoperative
macroscopic identification of a pus-filled uterus, positive
bacterial culture from the uterine content and histopatho-
logical examination of formaldehyde-fixated uteri and
ovaries (inclusion criteria as previously described for
the pyometra group included in a study published earl-
ier). Bitches with the histopathological diagnosis muco-
metra, hydrometra or cystic endometrial hyperplasia
were excluded [44].
The admitting clinician completed a form specifying
body temperature (BT), heart rate (HR), respiratory rate
(RR), mucus membrane color, capillary refilling time
(CRT), pain response at abdominal palpation, hydration
status and general attitude at the time of admission [44].
In general, bitches that are surgically treated for pyo-
metra are hospitalized at UDS for 1–2 days after surgery.
Only bitches with specific complications or poor general
condition stay longer in the animal hospital and ≥3 days
hospitalization was therefore defined as prolonged.
Sepsis
Sepsis was defined as presence of SIRS caused by infec-
tion (pyometra). Presence of SIRS was determined ac-
cording to definitions and criteria by Hauptman and
others (1997) [42], with fulfilment of two or more of
the following criteria: (1) Body temperature (BT) < 38.1°C
(100.4°F) or > 39.2°C (102.6°F); (2) Heart rate (HR) > 120
beats per min; (3) Respiratory rate (RR) > 20 breaths per
minute; and Total white blood cell count (WBC) < 6 or >
16 × 103/μL, or percentage band neutrophils (PBN) > 3%.
Bacterial culturing
Samples were immediately collected from the content
of the removed uterus with sterile fiber cotton swabs
(Culturette; Becton-Dickinson AG, Stockholm, Sweden).
Bacterial cultures and sensitivity tests were performed at
the accredited laboratory, Section of Bacteriology, National
Veterinary Institute (SVA), Uppsala, Sweden as earlier de-
scribed [56].
Blood sampling and laboratory tests
Hematological and, biochemical analyses
Prior to surgery, blood samples for hematology and bio-
chemistry were aseptically collected from the distal
cephalic vein and transferred into EDTA and non-
additive collection tubes (Vacutainer®, Becton-Dickinson,
Stockholm, Sweden). The non-additive tubes were cen-
trifuged and serum separated before analysis of bio-
chemistry parameters. Hematological (WBC including
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(Hb)) and biochemical (Bile acids, Alanine aminotransfer-
ase (ALT), glucose Blood urea nitrogen (BUN), and Cre-
atinine) were performed (Advia 2120; Siemens Healthcare
Diagnostics, Deer-field, IL, USA for hematology and
Abbott Architect c4000, Abbott Park, IL, USA, for bio-
chemistry). Albumin was analyzed with a colorimetric
method (bromocresol green) using an automated analyzer
(Abbott Architect c4000, Abbott Park, IL, USA) with a
commercial albumin reagent from Abbott Laboratories.
All laboratory analyses were performed according to the
routine methods at the accredited Clinical pathology la-
boratory, UDS, SLU, Uppsala, Sweden. After centrifuga-
tion, all serum not used for biochemistry analyses was
directly transferred in aliquots of 200 μl to cryogenic
vials (NuncCryoTubes, VWR International, Stockholm,
Sweden), and freeze-stored at −80°C until analysis of
SAA and CRP, up to eight months before analysis. Blood
samples for bacterial cultures were aseptically collected
into a sterile syringe and 3 ml blood was added to two bi-
phasic aerobic and anaerobic medium blood culture bot-
tles (BOF, Substratlab, SVA, Uppsala, Sweden). The BOFs
were transported to the accredited laboratory, Section
of Bacteriology, SVA, Uppsala, Sweden, cultured in 37°C
for 7 days or until growth and bacterial strains subse-
quently typed.
Analysis of acute phase proteins
Analysis of SAA was performed by trained laboratory
staff at the Clinical Pathology Laboratory, UDS, with a
commercially available ELISA (Tridelta Phase™ Range
SAA Assay, Tridelta Development Limited, County
Kildare, Ireland), with mean intra- and inter-assay coef-
ficients of variation of 4.75% and 8.8%, respectively, and
with the lowest measurable concentration of 10 mg/L.
The absorbance was evaluated using Tecan Sunrise
reader (Tecan Inc., Männedorf, Switzerland). The
method has previously been validated for dogs [49]. A
human immunoturbidimetric CRP assay that has been
validated for dogs, was used to measure serum CRP
concentrations [50]. The analyses were performed on
Abbot Architect (Abbott Architect c4000, Abbott Park,
IL, USA) and the method was calibrated with canine
CRP (Life Diagnostics canine CRP, West Chester, USA).
The lowest measurable concentration was 5 mg/L with
a mean intra- and interassay variation were 1.4% and
2.4%. Samples with high concentrations of CRP (above
217 and 225 mg/L for the two lots used) were autodi-
luted 1:3 with 0.9% NaCl and reanalyzed to obtain exact
values.
Statistical analyses
All statistical analyses were performed by the use of
SAS 9.3 package (SAS Institute Inc. Cary, NC, USA).ANOVA was used to evaluate the differences in SAA,
CRP and albumin results between septic and non-septic
groups and to investigate possible relations between in-
flammatory markers and morbidity as measured by in-
creased postoperative hospitalization. Residual diagnostic
plots were used to assess normality and homoscedasticity.
The diagnostic power of different markers was assessed
using logistic regression [57]. The area under curve (AUC)
was used as a measure of diagnostic ability. The cut-off
value was selected as upper 5% limit in the non-septic
group [58].
The significance level was set to p < 0.05 for all tests
used in the study.
Descriptive data was described as mean ± SE. Bitches
with concentrations below the lowest measurable con-
centration were assigned a value of half that value for
the statistical analyses.
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